NASDAQ® NeuroInsights® Neurotech Index Components
The Index includes companies researching, developing, manufacturing, and marketing pharmaceuticals, biologics, medical devices and diagnostics for the brain and nervous system. Index companies are defined by NeuroInsights as significantly involved in neurotechnology and must meet rigorous market criteria including a $200 million market capitalization and a three month average daily trading volume of 100,000 shares. |
|
Company
|
Symbol
|
Index weight (%)
|
1 mo
return (%)
|
3 mo
return (%)
|
1 yr
return (%)
|
Market Cap ($M)
|
Ave. Daily Volume (Shares)
|
Last Price
|
52 Week Low
|
52 Week High
|
|
Acadia Pharmaceuticals
|
ACAD
|
2.26%
|
2%
|
10%
|
62%
|
568
|
244,381
|
15.38
|
6.63
|
17.33
|
|
Acorda Therapeutics
|
ACOR
|
2.17%
|
10%
|
21%
|
14%
|
576
|
204,792
|
20.27
|
14.41
|
26.58
|
|
Alexza Pharmaceuticals
|
ALXA
|
1.08%
|
-6%
|
-7%
|
0%
|
251
|
115,629
|
8.14
|
7.12
|
15.8
|
|
Alkermes, Inc.
|
ALKS
|
4.00%
|
-12%
|
14%
|
-4%
|
1651
|
1,122,757
|
16.20
|
12.81
|
18.78
|
|
Arena Pharmaceuticals
|
ARNA
|
3.48%
|
-12%
|
-16%
|
-37%
|
587
|
1,042,416
|
9.61
|
8.97
|
15.7
|
|
Aspect Medical Systems
|
ASPM
|
1.04%
|
1%
|
1%
|
-23%
|
267
|
138,940
|
13.69
|
11.84
|
21.35
|
|
Biogen Idec Inc.
|
BIIB
|
8.00%
|
12%
|
32%
|
56%
|
21838
|
5,536,714
|
74.44
|
42.86
|
84.75
|
|
Biovail Corporation
|
BVF
|
4.00%
|
15%
|
7%
|
41%
|
3210
|
693,872
|
20.01
|
15.30
|
26.48
|
|
Cephalon, Inc.
|
CEPH
|
8.00%
|
1%
|
-2%
|
5%
|
4930
|
1,151,750
|
73.74
|
64.65
|
84.83
|
|
Cyberonics, Inc.
|
CYBX
|
1.71%
|
4%
|
4%
|
-20%
|
390
|
212,877
|
14.5
|
12.95
|
27.55
|
|
Cypress Bioscience, Inc.
|
CYPB
|
2.11%
|
-1%
|
17%
|
71%
|
504
|
302,449
|
13.49
|
6.91
|
18.20
|
|
DURECT Corporation
|
DRRX
|
1.50%
|
6%
|
35%
|
25%
|
404
|
268,132
|
5.82
|
3.6
|
6.00
|
|
Elan Corporation, plc
|
ELN
|
8.00%
|
13%
|
27%
|
64%
|
11126
|
3,148,925
|
23.80
|
11.7
|
24.75
|
|
Endo Pharmaceuticals
|
ENDP
|
4.00%
|
-6%
|
-14%
|
3%
|
3927
|
1,613,634
|
29.30
|
26.68
|
35.85
|
|
Forest Laboratories, Inc.
|
FRX
|
8.00%
|
5%
|
-3%
|
-20%
|
12352
|
3,489,316
|
39.07
|
35.01
|
57.97
|
|
Integra LifeSciences
|
IART
|
4.00%
|
0%
|
-2%
|
31%
|
1273
|
206,465
|
48.47
|
36.36
|
52.85
|
|
Javelin Pharmaceuticals
|
JAV
|
1.10%
|
5%
|
28%
|
---
|
257
|
---
|
5.29
|
---
|
---
|
|
Medivation, Inc.
|
MDVN
|
2.06%
|
4%
|
27%
|
78%
|
581
|
339,298
|
20.89
|
11.01
|
25.06
|
|
Micrus Endovascular
|
MEND
|
1.55%
|
8%
|
-16%
|
47%
|
302
|
147,087
|
19.65
|
13.25
|
25.78
|
|
Natus Medical, Inc.
|
BABY
|
1.48%
|
14%
|
19%
|
9%
|
392
|
196,186
|
18.10
|
13.87
|
18.99
|
|
Neurocrine Biosciences
|
NBIX
|
1.61%
|
-8%
|
-9%
|
-20%
|
351
|
694,643
|
9.25
|
7.51
|
14.88
|
|
Neurogen Corporation
|
NRGN
|
0.88%
|
-11%
|
-7%
|
-34%
|
165
|
129,607
|
3.94
|
3.47
|
8.75
|
|
Northstar Neuroscience
|
NSTR
|
1.25%
|
19%
|
29%
|
-12%
|
343
|
218,489
|
13.25
|
9.59
|
15.27
|
|
Pain Therapeutics, Inc.
|
PTIE
|
1.76%
|
10%
|
22%
|
23%
|
452
|
211,554
|
10.26
|
7.00
|
11.00
|
|
Penwest Pharmaceuticals
|
PPCO
|
1.23%
|
-25%
|
-35%
|
-53%
|
194
|
1,246,552
|
8.29
|
7.35
|
18.68
|
|
Sepracor Inc.
|
SEPR
|
4.00%
|
0%
|
-2%
|
-47%
|
2955
|
2,651,623
|
27.54
|
22.25
|
63.24
|
|
Shire plc
|
SHPGY
|
8.00%
|
2%
|
2%
|
37%
|
13860
|
860,915
|
75.15
|
53.64
|
81.00
|
|
Somanetics Corporation
|
SMTS
|
1.09%
|
5%
|
11%
|
-9%
|
257
|
88,424
|
19.46
|
16.16
|
23.63
|
|
Somaxon Pharmaceuticals
|
SOMX
|
0.96%
|
-12%
|
-10%
|
-39%
|
163
|
77,588
|
8.92
|
8.85
|
18.57
|
|
Valeant Pharmaceuticals
|
VRX
|
4.00%
|
-6%
|
-7%
|
-22%
|
1338
|
546,304
|
14.55
|
14.19
|
19.15
|
|
Vanda Pharmaceuticals
|
VNDA
|
1.69%
|
8%
|
-20%
|
15%
|
399
|
612,696
|
15.00
|
8.95
|
32.00
|
|
XenoPort, Inc.
|
XNPT
|
4.00%
|
4%
|
15%
|
104%
|
1224
|
182,476
|
49.08
|
22.41
|
50.99
|
|
Source: NeuroInsights, NASDAQ, Morningstar as of 10/31/2007 |
|